Molecule Details
InChIKeySTJMRWALKKWQGH-UHFFFAOYSA-N
Compound NameClenbuterol
Canonical SMILESCC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)2
Pfam Stratification Homologous
Avg pChEMBL7.25
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB01407
Drug NameClenbuterol
CAS Number37148-27-9
Groups approved investigational vet_approved
ATC Codes R03CC13 R03AC14 R03CC63
DescriptionA substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.

Categories: Adrenergic Agents Adrenergic Agonists Adrenergic beta-2 Receptor Agonists Adrenergic beta-Agonists Adrenergics for Systemic Use Adrenergics, Inhalants Agents producing tachycardia Agents that produce hypertension Agents to Treat Airway Disease Alcohols Amines Amino Alcohols Anti-Asthmatic Agents Autonomic Agents Bronchodilator Agents Cytochrome P-450 CYP1A1 Substrates Cytochrome P-450 Substrates Drugs for Obstructive Airway Diseases Ethanolamines Long-acting beta-adrenoceptor agonists Neurotransmitter Agents Peripheral Nervous System Agents Respiratory System Agents Selective Beta 2-adrenergic Agonists Sympathomimetics
Cross-references: BindingDB: 27958 ChEBI: 174690 CHEMBL49080 ChemSpider: 2681 Drugs Product Database (DPD): 20239 PharmGKB: PA164745640 PubChem:2783 PubChem:46508373 RxCUI: 2580 Therapeutic Targets Database: DAP000945 Wikipedia: Clenbuterol
Target Activities (2)
Target Gene Organism Category Pfam pChEMBL Type Source
P07550 ADRB2 Homo sapiens Human PF00001 7.5 Ki ChEMBL;BindingDB
P08588 ADRB1 Homo sapiens Human PF00001 7.0 IC50 ChEMBL
DrugBank Target Actions (6)
Target Gene Target Name Action Type
P04798 CYP1A1 Cytochrome P450 1A1 substrate enzymes
P07550 ADRB2 Beta-2 adrenergic receptor agonist targets
P08588 ADRB1 Beta-1 adrenergic receptor agonist targets
P13945 ADRB3 Beta-3 adrenergic receptor agonist targets
P01375 TNF Tumor necrosis factor other/unknown targets
P01138 NGF Beta-nerve growth factor stimulator targets